Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 16, 2022; 10(35): 13129-13137
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13129
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13129
Figure 2 Hepatocellular carcinoma and neuroendocrine carcinoma tumors.
A: Tumor of the right lobe of the liver, 5.7 cm × 5 cm × 4.5 cm, a collision type “hepatocellular carcinoma-hepatic neuroendocrine carcinoma” (HCC-NEC). HCC and NECs coexisted without clear delineation by gross features; B: HE 200X left: NEC, Right: HCC; collision type tumor (right liver tumor). HCC and NEC coexisted and were distinguishable by microscopic features without a focal transition. In addition, HE 400X left: NEC, Right: HCC; C: Synaptophysin 200X LEFT: NEC, right: HCC (collision type, right liver). Synaptophysin positivity in NEC; D: Chromogranin A 200X left: NEC, right: HCC (collision type, right liver). Chromogranin A is positive in NEC; E: A pure HCC (1.6 cm × 1 cm × 0.7 cm) in the resected segment 2 liver.
- Citation: Jeng KS, Huang CC, Chung CS, Chang CF. Liver collision tumor of primary hepatocellular carcinoma and neuroendocrine carcinoma: A rare case report. World J Clin Cases 2022; 10(35): 13129-13137
- URL: https://www.wjgnet.com/2307-8960/full/v10/i35/13129.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i35.13129